Comparative Pharmacology
Head-to-head clinical analysis: FLUTEX versus NUTRACORT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FLUTEX versus NUTRACORT.
FLUTEX vs NUTRACORT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Flutamide is a nonsteroidal antiandrogen that competitively inhibits the binding of dihydrotestosterone (DHT) to androgen receptors in target tissues, thereby blocking the androgenic effects.
Corticosteroid receptor agonist; induces anti-inflammatory proteins and suppresses inflammatory mediators.
50 mg orally once daily
One capsule (200 mg) orally twice daily with meals.
None Documented
None Documented
Terminal elimination half-life: 24–36 hours, permitting once-daily dosing in chronic therapy
Terminal half-life: 2-4 hours (mean 3 hours). Clinically, dosing every 6-8 hours maintains therapeutic levels.
Renal: ~70% (50% unchanged, 20% as metabolites); Biliary/fecal: ~30%
Renal (primarily as glucuronide and sulfate conjugates, <10% unchanged) and fecal (biliary excretion of metabolites). Approximately 70-80% renal, 20-30% fecal.
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid